Form 10-Q 89bio, Inc. For: Jun 30

Go back to Form 10-Q 89bio, Inc. For: Jun 30

89bio Inc. (ETNB) PT Lowered to $12 at RBC Capital

August 6, 2024 6:41 AM EDT

RBC Capital analyst Brian Abrahams lowered the price target on 89bio Inc. (NASDAQ: ETNB) to $12.00 (from $13.00) while maintaining a Sector Perform rating.

The analyst comments "Both ph.III studies in MASH have been initiated and are enrolling. While we like pegoza's likely role... More